Xyrem Antitrust MDL Judge OKs 3 Classes, Approves $3.4M Pact With 2 Defendants

Mealey's (May 26, 2023, 5:57 PM EDT) -- SAN FRANCISCO — A California federal judge overseeing the Xyrem antitrust multidistrict litigation certified three classes of claimants against two drug companies and granted preliminary approval of a $3.4 million settlement of claims that the defendants conspired to keep a generic version of the narcolepsy drug off the market....